Monomethyl fumarate-carrier conjugates and methods of their use

Disclosed are conjugates of monomethyl fumarate and a carrier group or aminocarrier group, or a pharmaceutically acceptable salt thereof. In the conjugates, monomethyl fumarate acyl is covalently bonded to the carrier group or aminocarrier group through a carbon-oxygen bond that is cleavable in vivo...

Full description

Saved in:
Bibliographic Details
Main Authors BRIGGS, Timothy, GUNASEKERA, Dinara Shashanka, NUDEL, Kathleen, PECK, Spencer Cory, YASUDA, Koji, ALEXANDER, Jessica Elizabeth, CASEY Jr., John, LIANG, Anna, KIM, Mi-Jeong, BUCKBINDER, Leonard, KAMALI SARVESTANI, Afrand, LANTER, Bernard, TAYLOR, Steven John, BERRY, David Arthur, ROSS, Cheri
Format Patent
LanguageEnglish
Published 10.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are conjugates of monomethyl fumarate and a carrier group or aminocarrier group, or a pharmaceutically acceptable salt thereof. In the conjugates, monomethyl fumarate acyl is covalently bonded to the carrier group or aminocarrier group through a carbon-oxygen bond that is cleavable in vivo. The carrier group may include a core, e.g., a monosaccharide, a sugar acid (e.g., acid monosaccharide), a sugar alcohol, or a catechin polyphenol. The aminocarrier group may include a core, e.g., an aminomonosaccharide. The carrier group or aminocarrier group may include, e.g., at least one short chain fatty acid acyl, at least one tryptophan analogue, at least one ketone body, or at least one preketone body. Also disclosed are pharmaceutical compositions containing the conjugates and methods of their use.
Bibliography:Application Number: AU20190392784